Learning objectives: Provide a summary of regulatory pathways that may be used to make products available in emergency situations.
Summarize the characteristics of the available COVID-19 vaccines.
Session date:
10/19/2021 - 12:00pm to 1:00pm CDT
Location:
Virtual/P-117
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Peter W. Marks, MD, PhD